Announced
Financials
Tags
Acquisition
Private
pharmacy services
Single Bidder
United States
referral management
IVIG therapy
infusion services
Health Care Services
Domestic
Majority
Private Equity
Pending
Friendly
Synopsis
Ridgemont Equity Partners, a growth equity investor, agreed to acquire American Outcomes Management, a provider of home-based intravenous immunoglobulin therapy. Financial terms were not disclosed. “AOM has a tremendous growth opportunity ahead and several avenues for expansion, Our vision for the business starts with investing in our team and capabilities to expand our presence in all geographic markets and offer additional specialty infusion therapies. Infusion services continue to shift out of the hospital setting towards alternative sites as patients, providers and payors prefer the comfort and cost-effectiveness of at-home treatment. With Ridgemont’s support, AOM can broaden its reach and help more people in our communities find long-term care solutions,” Chris York, AOM Chairman.
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.